Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY)

53 filings reported holding INZY - Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share as of Q2 2022.
Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 31.5M shares of 64.5M outstanding shares and own 48.83% of the company stock.
Largest 10 shareholders include Sofinnova Investments, Inc. (3.66M shares), Deep Track Capital, LP (3.25M shares), VR Adviser, LLC (2.71M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.7M shares), Pivotal bioVenture Partners Investment Advisor LLC (2.66M shares), Rock Springs Capital Management LP (2.64M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.55M shares), NEA Management Company, LLC (2.44M shares), CHI Advisors LLC (2.03M shares), and VANGUARD GROUP INC (1.35M shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.